Outlook Therapeutics, Inc. SEC filings OTLK
Outlook Therapeutics, Inc. has 833 filings in SEC EDGAR's recent list, going back to Aug 10, 2015. Its latest annual report, Form ARS, was filed on Jan 26, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 18, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (listing notice). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Aug 14, 2026 | — |
| 424B5 | Prospectus supplement | Aug 12, 2026 | — |
| 424B3 | Prospectus | Jul 21, 2026 | — |
| S-3 | Shelf registration | Jul 17, 2026 | — |
| 424B5 | Prospectus supplement | May 29, 2026 | — |
| 424B5 | Prospectus supplement | May 13, 2026 | — |
| 424B5 | Prospectus supplement | Apr 23, 2026 | — |
| 424B5 | Prospectus supplement | Mar 25, 2026 | — |
| 424B5 | Prospectus supplement | Mar 23, 2026 | — |
| 424B5 | Prospectus supplement | May 23, 2025 | — |
| 424B5 | Prospectus supplement | May 22, 2025 | — |
| 424B3 | Prospectus | May 14, 2025 | — |
| 424B3 | Prospectus | May 14, 2025 | — |
| 424B3 | Prospectus | Mar 28, 2025 | — |
| S-3 | Shelf registration | Mar 20, 2025 | — |
| 424B3 | Prospectus | Mar 7, 2025 | — |
| S-3 | Shelf registration | Feb 28, 2025 | — |
| S-8 | Employee stock plan registration | Aug 14, 2024 | — |
| 424B3 | Prospectus | May 6, 2024 | — |
| S-3 | Shelf registration | Apr 26, 2024 | — |
| 424B5 | Prospectus supplement | Apr 12, 2024 | — |
| 424B3 | Prospectus | Apr 1, 2024 | — |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| S-3 | Shelf registration | Mar 28, 2024 | — |
| S-3 | Shelf registration | Mar 25, 2024 | — |
| 424B5 | Prospectus supplement | Aug 25, 2023 | — |
| S-3 | Shelf registration | Aug 14, 2023 | — |
| 424B5 | Prospectus supplement | May 16, 2023 | — |
| S-8 | Employee stock plan registration | Feb 14, 2023 | — |
| 424B5 | Prospectus supplement | Dec 23, 2022 | — |
| 424B5 | Prospectus supplement | Jun 17, 2022 | — |
| S-8 | Employee stock plan registration | Feb 15, 2022 | — |
| 424B5 | Prospectus supplement | Nov 24, 2021 | — |
| FWP | Free writing prospectus | Nov 24, 2021 | — |
| FWP | Free writing prospectus | Nov 23, 2021 | — |
| 424B5 | Prospectus supplement | Nov 23, 2021 | — |
| S-3 | Shelf registration | Mar 26, 2021 | — |
| S-8 | Employee stock plan registration | Mar 26, 2021 | — |
| 424B5 | Prospectus supplement | Mar 26, 2021 | — |
| 424B5 | Prospectus supplement | Feb 1, 2021 | — |
| FWP | Free writing prospectus | Jan 29, 2021 | — |
| FWP | Free writing prospectus | Jan 28, 2021 | — |
| 424B5 | Prospectus supplement | Jan 28, 2021 | — |
| 424B5 | Prospectus supplement | Jun 23, 2020 | — |
| 424B3 | Prospectus | May 29, 2020 | — |
| S-8 | Employee stock plan registration | May 15, 2020 | — |
| 424B3 | Prospectus | Apr 17, 2020 | — |
| S-1 | Registration statement | Apr 8, 2020 | — |
| 424B5 | Prospectus supplement | Feb 24, 2020 | — |
| S-8 | Employee stock plan registration | Feb 14, 2020 | — |
| 424B3 | Prospectus | Dec 23, 2019 | — |
| S-8 | Employee stock plan registration | Sep 30, 2019 | — |
| 424B3 | Prospectus | Jun 14, 2019 | — |
| S-3 | Shelf registration | Jun 3, 2019 | — |
| 424B4 | Prospectus | Apr 10, 2019 | — |
| S-1MEF | Filing | Apr 10, 2019 | — |
| S-1/A | Amended registration statement | Apr 9, 2019 | — |
| S-1/A | Amended registration statement | Apr 2, 2019 | — |
| S-1/A | Amended registration statement | Mar 19, 2019 | — |
| S-1/A | Amended registration statement | Mar 7, 2019 | — |
| 424B3 | Prospectus | Mar 1, 2019 | — |
| S-1 | Registration statement | Feb 21, 2019 | — |
| S-8 | Employee stock plan registration | Feb 14, 2019 | — |
| POS AM | Post-effective amendment no. 2 to form s-1 | Feb 14, 2019 | — |
| POS AM | Filing | Mar 27, 2018 | — |
| S-8 | Employee stock plan registration | Feb 15, 2018 | — |
| S-3 | Shelf registration | Feb 15, 2018 | — |
| POS AM | Filing | Feb 15, 2018 | — |
| POS AM | Post-effective amendment no.1 to form s-1 | Feb 15, 2018 | — |
| S-3 | Shelf registration | Jan 2, 2018 | — |
| 424B3 | Prospectus | Aug 15, 2017 | — |
| 424B3 | Prospectus | Aug 15, 2017 | — |
| 424B3 | Prospectus | Aug 15, 2017 | — |
| 424B3 | Prospectus | Aug 15, 2017 | — |
| 424B3 | Prospectus | May 16, 2017 | — |
| 424B3 | Prospectus | May 16, 2017 | — |
| 424B3 | Prospectus | May 16, 2017 | — |
| 424B3 | Prospectus | May 16, 2017 | — |
| 424B3 | Prospectus | Mar 23, 2017 | — |
| S-1 | Registration statement | Mar 10, 2017 | — |
| 424B3 | Prospectus | Mar 2, 2017 | — |
| S-8 | Employee stock plan registration | Feb 15, 2017 | — |
| S-1 | Registration statement | Feb 15, 2017 | — |
| 424B3 | Prospectus | Feb 14, 2017 | — |
| 424B3 | Prospectus | Feb 14, 2017 | — |
| 424B3 | Prospectus | Feb 7, 2017 | — |
| 424B3 | Prospectus | Feb 7, 2017 | — |
| 424B3 | Prospectus | Jan 17, 2017 | — |
| 424B3 | Prospectus | Jan 17, 2017 | — |
| POS AM | Post-effective amendment no.1 to form s-1 | Jan 5, 2017 | — |
| POS AM | Post-effective amendment no.1 to form s-1 | Jan 5, 2017 | — |
| 424B3 | Prospectus | Aug 15, 2016 | — |
| 424B3 | Prospectus | Aug 15, 2016 | — |
| 424B3 | Prospectus | Jul 14, 2016 | — |
| S-1 | Registration statement | Jun 30, 2016 | — |
| 424B3 | Prospectus | Jun 27, 2016 | — |
| S-8 | Employee stock plan registration | May 13, 2016 | — |
| 424B4 | Prospectus | May 13, 2016 | — |
| S-1/A | Amended registration statement | May 11, 2016 | — |
| S-1/A | Amended registration statement | May 4, 2016 | — |
| S-1/A | Amended registration statement | Apr 27, 2016 | — |
| S-1/A | Amended registration statement | Feb 26, 2016 | — |
| S-1/A | Amended registration statement | Feb 12, 2016 | — |
| S-1 | Registration statement | Jan 15, 2016 | — |
Showing 104 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- OTLK (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- DE
- Headquarters
- Iselin, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1649989
- Former names
- Oncobiologics, Inc. (until Nov 13, 2018)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.